Friday December 6, 2019

Genetic harvesting firm ordered to contact brain tumour patients

Brain tumour patients must be informed of right to withdraw data from study

Killian Woods

Business reporter

@killianwoods

Barry J Whyte

Chief Feature Writer

@whytebarry
24th November, 2019

Genomics Medicine Ireland (GMI) has been ordered to run a publicity campaign to allow people to withdraw their samples from a project to harvest the genetic data of 9,000 Irish brain tumour patients.

GMI was founded in 2015 and secured funding from Google and a venture firm established by ex-Starbucks chief executive Howard Schultz. It was acquired by WuXi NextCODE in 2018 and, as part of the deal, the Irish government’s sovereign wealth fund put $70...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Irish Cancer Society investigating whether patient data was shared with genetic data collection firm without consent

Killian Woods | 5 days ago

The group recorded strong full-year results, with profits of over $158m

Peter O'Dwyer | 5 days ago